Found: 1
Select item for more details and to access through your institution.
Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study.
- Published in:
- Therapeutic Advances in Hematology, 2018, v. 9, n. 3, p. 65, doi. 10.1177/2040620718756603
- By:
- Publication type:
- Article